Author:
Bettica Paolo,Squassante Lisa,Groeger John A,Gennery Brian,Winsky-Sommerer Raphaelle,Dijk Derk-Jan
Publisher
Springer Science and Business Media LLC
Subject
Psychiatry and Mental health,Pharmacology
Reference45 articles.
1. Beersma DG, Daan S, Van den Hoofdakker RH (1984). Distribution of REM latencies and other sleep phenomena in depression as explained by a single ultradian rhythm disturbance. Sleep 7: 126–136.
2. Bettica P, Nucci G, Pyke C, Squassante L, Zamuner S, Ratti E et al (2011). Phase I studies on the safety, tolerability, pharmacokinetics and pharmacodynamics of SB-649868, a novel dual orexin receptor antagonist. J Psychopharmacol; e-pub ahead of print 5 July 2011.
3. Boyle J, Wolford D, Gargano C, McCrea J, Cummings C, Cerchio K et al (2009). Next-day residual effects of gaboxadol and flurazepam administered at bedtime: a randomized double-blind study in healthy elderly subjects. Hum Psychopharmacol 24: 61–71.
4. Brisbare-Roch C, Dingemanse J, Koberstein R, Hoever P, Aissaoui H, Flores S et al (2007). Promotion of sleep by targeting the orexin system in rats, dogs and humans. Nat Med 13: 150–155.
5. Brown RE, Sergeeva O, Eriksson KS, Haas HL (2001). Orexin A excites serotonergic neurons in the dorsal raphe nucleus of the rat. Neuropharmacology 40: 457–459.
Cited by
81 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献